Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model

By Xu Bei-Bei   Liu Chun-Qing   Gao Xi   Zhang Wan-Qin   Wang Shi-Wei   Cao Ying-Lin  

Journal of Asian Natural Products Research, Vol. 7, Iss. 3, 2005-06 ,pp. : 215-224

Taylor & Francis Ltd

Access to resources Recommend Favorite

Neuroprotective Effect of Gypenosides against Oxidative Injury in the Substantia Nigra of a Mouse Model of Parkinson's Disease

By Wang P   Niu L   Gao L   Li W-X   Jia D   Wang X-L   Gao G-D  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1084-1092

Field House Publishing

Access to resources Recommend Favorite

Inflammatory Process as a Determinant Factor for the Degeneration of Substantia Nigra Dopaminergic Neurons: Possible Relevance to the Etiology of Parkinson's Disease

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 4, 2004-12 ,pp. : 223-233

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata

By Miller A.S.   Walker J.M.  

European Journal of Pharmacology, Vol. 279, Iss. 2, 1995-06 ,pp. : 179-185

Elsevier

Access to resources Recommend Favorite

Muscarinic antagonists in substantia nigra influence the decarboxylation of l-dopa in striatum

By Izurieta-Sanchez P.   Sarre S.   Ebinger G.   Michotte Y.  

European Journal of Pharmacology, Vol. 399, Iss. 2, 2000-07 ,pp. : 151-160

Elsevier

Access to resources Recommend Favorite